Latest Insider Transactions at Hca Healthcare, Inc. (HCA)
This section provides a real-time view of insider transactions for Hca Healthcare, Inc. (HCA). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of HCA Healthcare, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of HCA Healthcare, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Apr 25
2022
|
Robert J Dennis Director |
BUY
Grant, award, or other acquisition
|
Direct |
902
+3.69%
|
-
|
|
Apr 25
2022
|
Thomas F Frist Iii Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,899
+14.93%
|
-
|
|
Apr 25
2022
|
Nancy Ann Deparle Director |
BUY
Grant, award, or other acquisition
|
Direct |
902
+4.42%
|
-
|
|
Apr 25
2022
|
William R Frist Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,424
+12.58%
|
-
|
|
Apr 25
2022
|
Charles O Holliday Jr Director |
BUY
Grant, award, or other acquisition
|
Direct |
902
+4.54%
|
-
|
|
Apr 25
2022
|
Hugh F Johnston Director |
BUY
Grant, award, or other acquisition
|
Direct |
902
+39.75%
|
-
|
|
Apr 25
2022
|
Michael W Michelson Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,424
+14.8%
|
-
|
|
Apr 25
2022
|
Wayne Joseph Riley Director |
BUY
Grant, award, or other acquisition
|
Direct |
902
+6.68%
|
-
|
|
Apr 25
2022
|
Andrea B Smith Director |
BUY
Grant, award, or other acquisition
|
Direct |
902
+45.53%
|
-
|
|
Mar 11
2022
|
Joseph A Sowell Iii SVP; Chief Development Officer |
SELL
Open market or private sale
|
Direct |
11,522
-40.32%
|
$3,099,418
$269.0 P/Share
|
|
Feb 18
2022
|
Jennifer Berres SVP & Chief Human Res. Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,827
-17.05%
|
$689,788
$244.1 P/Share
|
|
Feb 18
2022
|
Jennifer Berres SVP & Chief Human Res. Officer |
BUY
Grant, award, or other acquisition
|
Direct |
8,720
+23.38%
|
-
|
|
Feb 18
2022
|
Phillip G Billington SVP-Internal Audit Services |
SELL
Payment of exercise price or tax liability
|
Direct |
1,224
-2.93%
|
$298,656
$244.1 P/Share
|
|
Feb 18
2022
|
Phillip G Billington SVP-Internal Audit Services |
BUY
Grant, award, or other acquisition
|
Direct |
4,640
+10.0%
|
-
|
|
Feb 18
2022
|
Jeffrey E. Cohen SVP-Government Relations |
SELL
Payment of exercise price or tax liability
|
Direct |
1,634
-35.22%
|
$398,696
$244.1 P/Share
|
|
Feb 18
2022
|
Jeffrey E. Cohen SVP-Government Relations |
BUY
Grant, award, or other acquisition
|
Direct |
4,640
+50.0%
|
-
|
|
Feb 18
2022
|
Michael S. Cuffe EVP and Chief Clinical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
3,658
-12.7%
|
$892,552
$244.1 P/Share
|
|
Feb 18
2022
|
Michael S. Cuffe EVP and Chief Clinical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
10,840
+27.35%
|
-
|
|
Feb 18
2022
|
Jon M Foster EVP and COO |
SELL
Payment of exercise price or tax liability
|
Direct |
6,082
-35.73%
|
$1,484,008
$244.1 P/Share
|
|
Feb 18
2022
|
Jon M Foster EVP and COO |
BUY
Grant, award, or other acquisition
|
Direct |
17,020
+50.0%
|
-
|
|
Feb 18
2022
|
Charles J Hall Group President |
SELL
Payment of exercise price or tax liability
|
Direct |
6,082
-2.93%
|
$1,484,008
$244.1 P/Share
|
|
Feb 18
2022
|
Charles J Hall Group President |
BUY
Grant, award, or other acquisition
|
Direct |
17,020
+7.57%
|
-
|
|
Feb 18
2022
|
Samuel N Hazen CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
35,830
-8.64%
|
$8,742,520
$244.1 P/Share
|
|
Feb 18
2022
|
Samuel N Hazen CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
6,011
+1.43%
|
-
|
|
Feb 18
2022
|
Samuel N Hazen CEO |
BUY
Grant, award, or other acquisition
|
Direct |
85,040
+17.22%
|
-
|
|
Feb 18
2022
|
A Bruce Moore Jr Group President - Service Line |
SELL
Payment of exercise price or tax liability
|
Direct |
3,656
-3.56%
|
$892,064
$244.1 P/Share
|
|
Feb 18
2022
|
A Bruce Moore Jr Group President - Service Line |
BUY
Grant, award, or other acquisition
|
Direct |
10,840
+9.55%
|
-
|
|
Feb 18
2022
|
Sammie S Mosier SVP & Chief Nurse Executive |
SELL
Payment of exercise price or tax liability
|
Direct |
229
-3.44%
|
$55,876
$244.1 P/Share
|
|
Feb 18
2022
|
Sammie S Mosier SVP & Chief Nurse Executive |
BUY
Grant, award, or other acquisition
|
Direct |
940
+12.38%
|
-
|
|
Feb 18
2022
|
P. Martin Paslick SVP and CIO |
SELL
Payment of exercise price or tax liability
|
Direct |
3,046
-13.75%
|
$743,224
$244.1 P/Share
|
|
Feb 18
2022
|
P. Martin Paslick SVP and CIO |
BUY
Grant, award, or other acquisition
|
Direct |
9,280
+29.52%
|
-
|
|
Feb 18
2022
|
Deborah M Reiner SVP - Mktg. & Communications |
SELL
Payment of exercise price or tax liability
|
Direct |
1,223
-13.35%
|
$298,412
$244.1 P/Share
|
|
Feb 18
2022
|
Deborah M Reiner SVP - Mktg. & Communications |
BUY
Grant, award, or other acquisition
|
Direct |
4,640
+33.61%
|
-
|
|
Feb 18
2022
|
Bill B Rutherford CFO and EVP |
SELL
Payment of exercise price or tax liability
|
Direct |
8,821
-10.79%
|
$2,152,324
$244.1 P/Share
|
|
Feb 18
2022
|
Bill B Rutherford CFO and EVP |
BUY
Grant, award, or other acquisition
|
Direct |
23,980
+22.67%
|
-
|
|
Feb 18
2022
|
Joseph A Sowell Iii SVP; Chief Development Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
3,046
-9.63%
|
$743,224
$244.1 P/Share
|
|
Feb 18
2022
|
Joseph A Sowell Iii SVP; Chief Development Officer |
BUY
Grant, award, or other acquisition
|
Direct |
7,740
+19.67%
|
-
|
|
Feb 18
2022
|
Kathryn A. Torres SVP-Payer Contracting & Align. |
SELL
Payment of exercise price or tax liability
|
Direct |
1,836
-7.58%
|
$447,984
$244.1 P/Share
|
|
Feb 18
2022
|
Kathryn A. Torres SVP-Payer Contracting & Align. |
BUY
Grant, award, or other acquisition
|
Direct |
6,200
+20.39%
|
-
|
|
Feb 18
2022
|
Kathleen M Whalen SVP & Chief Ethics Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,224
-9.35%
|
$298,656
$244.1 P/Share
|
|
Feb 18
2022
|
Kathleen M Whalen SVP & Chief Ethics Officer |
BUY
Grant, award, or other acquisition
|
Direct |
4,640
+26.16%
|
-
|
|
Feb 18
2022
|
Christopher F. Wyatt SVP & Controller |
SELL
Payment of exercise price or tax liability
|
Direct |
1,836
-5.4%
|
$447,984
$244.1 P/Share
|
|
Feb 18
2022
|
Christopher F. Wyatt SVP & Controller |
BUY
Grant, award, or other acquisition
|
Direct |
6,200
+15.42%
|
-
|
|
Feb 17
2022
|
A Bruce Moore Jr Group President - Service Line |
SELL
Open market or private sale
|
Direct |
9,367
-9.26%
|
$2,369,851
$253.18 P/Share
|
|
Feb 16
2022
|
A Bruce Moore Jr Group President - Service Line |
SELL
Open market or private sale
|
Direct |
20,633
-16.94%
|
$5,034,452
$244.01 P/Share
|
|
Feb 09
2022
|
Kathleen M Whalen SVP & Chief Ethics Officer |
SELL
Bona fide gift
|
Direct |
420
-4.73%
|
-
|
|
Feb 03
2022
|
Sammie S Mosier SVP & Chief Nurse Executive |
SELL
Payment of exercise price or tax liability
|
Direct |
34
-0.59%
|
$8,160
$240.86 P/Share
|
|
Feb 03
2022
|
Sammie S Mosier SVP & Chief Nurse Executive |
BUY
Exercise of conversion of derivative security
|
Direct |
137
+2.33%
|
-
|
|
Jan 31
2022
|
Sammie S Mosier SVP & Chief Nurse Executive |
SELL
Payment of exercise price or tax liability
|
Direct |
66
-1.16%
|
$15,840
$240.05 P/Share
|
|
Jan 31
2022
|
Sammie S Mosier SVP & Chief Nurse Executive |
BUY
Exercise of conversion of derivative security
|
Direct |
273
+4.59%
|
-
|